Gregory Moyer

878 total citations
4 papers, 406 citations indexed

About

Gregory Moyer is a scholar working on Infectious Diseases, Virology and Molecular Biology. According to data from OpenAlex, Gregory Moyer has authored 4 papers receiving a total of 406 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 3 papers in Virology and 2 papers in Molecular Biology. Recurrent topics in Gregory Moyer's work include HIV/AIDS drug development and treatment (4 papers), HIV Research and Treatment (3 papers) and Pneumocystis jirovecii pneumonia detection and treatment (2 papers). Gregory Moyer is often cited by papers focused on HIV/AIDS drug development and treatment (4 papers), HIV Research and Treatment (3 papers) and Pneumocystis jirovecii pneumonia detection and treatment (2 papers). Gregory Moyer collaborates with scholars based in United States and Italy. Gregory Moyer's co-authors include Lori J. Gabryelski, William A. Schleif, Peter J. Felock, Steven D. Young, John Wai, Joseph P. Vacca, Kara A. Stillmock, Daria J. Hazuda, James P. Guare and Marc Witmer and has published in prestigious journals such as Journal of Medicinal Chemistry and Bioorganic & Medicinal Chemistry Letters.

In The Last Decade

Gregory Moyer

4 papers receiving 393 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gregory Moyer United States	4	244	206	165	114	50	4	406
Mark W. Embrey United States	4	172 0.7×	229 1.1×	178 1.1×	165 1.4×	48 1.0×	6	388
Thorsten E. Fisher United States	11	422 1.7×	247 1.2×	186 1.1×	219 1.9×	50 1.0×	15	643
Yvonne Leonard United States	5	165 0.7×	108 0.5×	86 0.5×	105 0.9×	23 0.5×	5	298
Karen R. Romines United States	14	440 1.8×	238 1.2×	192 1.2×	158 1.4×	95 1.9×	15	717
Vandna Munshi United States	13	227 0.9×	357 1.7×	278 1.7×	208 1.8×	105 2.1×	14	592
R W Buckheit United States	10	191 0.8×	221 1.1×	204 1.2×	161 1.4×	82 1.6×	14	502
Sanjeev Kumar V. Vernekar United States	13	271 1.1×	246 1.2×	181 1.1×	235 2.1×	53 1.1×	16	577
Janet C. Lynn United States	7	264 1.1×	163 0.8×	121 0.7×	110 1.0×	31 0.6×	10	465
Harvey I. Skulnick United States	10	284 1.2×	177 0.9×	120 0.7×	169 1.5×	42 0.8×	14	522
Yung‐hyo Koh United States	9	235 1.0×	156 0.8×	80 0.5×	169 1.5×	40 0.8×	10	397

Countries citing papers authored by Gregory Moyer

Since Specialization

Citations

This map shows the geographic impact of Gregory Moyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory Moyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory Moyer more than expected).

Fields of papers citing papers by Gregory Moyer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory Moyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory Moyer. The network helps show where Gregory Moyer may publish in the future.

Co-authorship network of co-authors of Gregory Moyer

This figure shows the co-authorship network connecting the top 25 collaborators of Gregory Moyer. A scholar is included among the top collaborators of Gregory Moyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregory Moyer. Gregory Moyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

4 of 4 papers shown

1.

Wolkenberg, S. E., Meiqing Lu, Vandna Munshi, et al.. (2007). Novel indole-3-sulfonamides as potent HIV non-nucleoside reverse transcriptase inhibitors (NNRTIs). Bioorganic & Medicinal Chemistry Letters. 18(2). 554–559. 76 indexed citations

2.

Guare, James P., John Wai, Robert Gomez, et al.. (2006). A series of 5-aminosubstituted 4-fluorobenzyl-8-hydroxy-[1,6]naphthyridine-7-carboxamide HIV-1 integrase inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(11). 2900–2904. 37 indexed citations

3.

Muraglia, Ester, Olaf Kinzel, Ralph Laufer, et al.. (2006). Tetrazole thioacetanilides: Potent non-nucleoside inhibitors of WT HIV reverse transcriptase and its K103N mutant. Bioorganic & Medicinal Chemistry Letters. 16(10). 2748–2752. 74 indexed citations

4.

Zhuang, Linghang, John Wai, Mark W. Embrey, et al.. (2003). Design and Synthesis of 8-Hydroxy-[1,6]Naphthyridines as Novel Inhibitors of HIV-1 Integrase in Vitro and in Infected Cells. Journal of Medicinal Chemistry. 46(4). 453–456. 219 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact